CURE - VanEck Genomics and Healthcare Innovators UCITS ETF (USD) (Acc) (IE000B9PQW54)

The VanEck Genomics and Healthcare Innovators UCITS ETF seeks to replicate as close as possible the price and yield performance of the MVIS Global Future Healthcare ESG Index by investing in a portfolio comprised primarily of genomics companies developing new ways to treat health problems such as genetic conditions, cancer and conditions related to ageing

The VanEck Genomics and Healthcare Innovators UCITS ETF (USD) (Acc) is a(n) Equity Exchange Traded Funds (ETF) seeks to invest in Healthcare sector located in Global. The VanEck fund’s base currency is USD and the share class was registered 06.12.2021 with unique ISIN - IE000B9PQW54. Main exchange is London S.E. (USD) and ticker symbol is CURE. The total expense ratio is 0.35%. The VanEck Genomics and Healthcare Innovators UCITS ETF (USD) (Acc) pays dividends 0 time(s) per year.